Prevalence of conventional risk factors in patients with coronary heart disease;Tradicinių rizikos veiksnių paplitimas tarp sergančiųjų išemine širdies liga

Medicina

Volumn 45, Issue 2, 2009, Pages 140-146

  Rinkuniene, Egidija ^a   Petrulioniene, Žaneta ^a   Laucevičius, Aleksandras ^a   Ringailaite, Ernesta ^b   Laučyte, Agne ^b  

^a VILNIUS UNIVERSITY   (Lithuania)

^b Medicinos fakultetas   (Lithuania)

Author keywords

Cardiovascular risk factors; Coronary heart disease

Indexed keywords

AGE; AGED; ANGINA PECTORIS; ARTICLE; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; LIFESTYLE; LITHUANIA; MALE; MIDDLE AGED; MORTALITY; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SMOKING; UNSTABLE ANGINA PECTORIS;

AGE FACTORS; AGED; ANGINA PECTORIS; ANGINA, UNSTABLE; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; LIFE STYLE; LITHUANIA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 65449157333     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.3390/medicina45020018     Document Type: Article

References (29)

1. Privalomojo sveikatos draudimo informacinės sistemos SVEIDRA duomenys
2. The health benefits of smoking cessation: a report of the Surgeon General. Rockville, Md: US Dept of Health and Human Services; 1990.
3. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-4.
4. Verschuren WM, Jacobs DR, Bloemberg BP, Kromhout D, Menotti A, Aravanis C, et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures: twenty-five-year follow-up of the Seven Countries Study. JAMA 1995;274:131-6.
5. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease, I: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-74.
6. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease, II: short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-38.
7. Hennekens CH. Increasing burden of cardiovascular disease: current knowledge and future directions for research on risk factors. Circulation 1998;97:1095-102.
8. Braunwald E. Shattuck lecture - cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997;337:1360-69.
9. McKechnie RS, Rubenfire M. The role of inflammation and infection in coronary artery disease: a clinical perspective. ACC Curr J Rev 2002;11:32-4.
10. Robinson K, Loscalzo J. Other risk factors for coronary artery disease: homocysteine, lipoprotein(a), fibrinogen, and plasminogen activator factor. In: Topol EJ, editor. Textbook of Cardiovascular Medicine. Philadelphia, Pa: Lippincott Williams & Wilkins; 2002. p. 200.
11. Futterman LG, Lemberg L. Fifty percent of patients with coronary artery disease do not have any of the conventional risk factors. Am J Crit Care 1998;7:240-4.
12. Fager G, Wiklund O. Cholesterol reduction and clinical benefit: are there limits to our expectations? Arterioscler Thromb Vasc Biol 1997;17:3527-33.
13. Prasad A, Zhu J, Halcox JP, Waclawiw MA, Epstein SE, Quyyumi AA. Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation 2002;106:184-90.
14. Tavazzi L. Clinical epidemiology of acute myocardial infarction. Am Heart J 1999;138(2 pt 2):S48-54.
15. Magnus P, Beaglehole R. The real contribution of the major risk factors to the coronary epidemics: time to end the "only-50%" myth. Arch Intern Med 2001;161:2657-60.
16. Stamler J, Stamler R, Neaton JD, Wentworth D, Daviglus ML, Garside D, et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 1999;282:2012-18.
17. Khot U, Khot M, Bajzer M, Sapp S, Ohman EM, Brener M, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2003;290:898-904.
18. Domarkienė S, Tamošiūnas A, Rėklaitienė R, Šidlauskienė D, Jurėnienė K, Margevičienė, et al. Trends in main cardiovascular risk factors among middle-aged Kaunas population between 1983 and 2002. Medicina (Kaunas) 2003;39(12): 1193-99.
19. Vaičaitienė R, Černiauskienė LR, Lukšienė DI, Margevičienė L. Hypercholesterolemia and smoking habits of Lithuanian military personnel. Military Medicine 2006;171(6):512-5.
20. Kristenson M, Ziedén B, Kucinskienė Z, Elinder LS, Bergdahl B, Elwing B, et al. Antioxidant state and mortality from coronary heart disease in Lithuanian and Swedish men: concomitant cross sectional study of men aged 50. BMJ 1997; 314:629-43.
21. Kirkutis A, Norkienė S, Gricienė P, Gricius J, Yang S, Gintautas J. Prevalence of hypertension in Lithuanian mariners. Proc West Pharmacol Soc 2004;47:71-5.
22. Yusuf S, Hawken S, Ounpuu S, on behalf of the INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52.
23. Tacoy G, Balcioglu AS, Akinci S, Erdem G, Kocaman SA, Timurkaynak T, et al. Traditional risk factors are predictive on segmental localization of coronary artery disease. Angiology 2008;59(4):402-7.
24. Stamler J, Vaccaro O, Neaton J, Wentworth D. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-44.
25. Chirinos JA, De Marchena E, Veerani A, Peter A, Khan N, Schob A, et al. Is diabetes a stronger predictor of recurrent cardiovascular events than the angiographic severity of coronary artery disease? Cardiovascular Disease: Epidemiology 2006;130(4):198s.
26. Šlapikas R, Lukšienė D, Šlapikienė B, Babarskienė MR, Grybauskienė R, Linonienė L. Prevalence of cardiovascular risk factors in coronary heart disease patients with different low-density lipoprotein phenotypes. Medicina (Kaunas) 2005; 41(11):925-31.
27. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 1991;265:627-31.
28. Keil U, Liese AD, Hense HW, Filipiak B, Doring A, Stieber J, et al. Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany: results from the MONICA Augsburg cohort study 1984-1992: Monitoring Trends and Determinants in Cardiovascular Diseases. Eur Heart J 1998; 19:1197-207.
29. Kahn R, Robertson RM, Smith R, Eddy D. The impact of prevention on reducing the burden of cardiovascular disease. Circulation 2008;118:576-85.